Latest & greatest articles for knee replacement

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on knee replacement or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on knee replacement and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for knee replacement

122. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. 14585938 2003 10 30 2003 11 05 2013 11 21 1533-4406 349 18 2003 Oct 30 The New England journal of medicine N. Engl. J. Med. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. 1703-12 In a previous study of the prevention of venous thromboembolism after total knee replacement, the efficacy of ximelagatran, an oral (...) with respect to major bleeding (incidence, 0.8 percent and 0.7 percent, respectively), perioperative indicators of bleeding, wound characteristics, or the composite secondary end point of proximal deep-vein thrombosis, pulmonary embolism, and death (2.7 percent vs. 4.1 percent; P=0.17). The efficacy of oral ximelagatran, administered starting the morning after total knee replacement, was superior to that of warfarin for prevention of venous thromboembolism. Rates of hemorrhagic complications with the two

NEJM2003

123. Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial.

Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. 14612477 2003 11 12 2003 11 25 2016 10 17 1538-3598 290 18 2003 Nov 12 JAMA JAMA Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. 2411-8 Controlling postoperative pain after knee (...) replacement while reducing opioid-induced adverse effects and improving outcomes remains an important challenge. To assess the effect of combined preoperative and postoperative administration of a selective inhibitor of cyclooxygenase 2 on opioid consumption and outcomes after total knee arthroplasty (TKA). Randomized, placebo-controlled, double-blind trial conducted June 2001 through September 2002, enrolling 70 patients aged 40 to 77 years and undergoing TKA at a university hospital in the United States

JAMA2003

124. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes

Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic (...) outcomes Douketis J D, Eikelboom J W, Quinlan D J, Willan A R, Crowther M A Authors' objectives To provide reliable estimates of the risk of symptomatic venous thromboembolism (VTE), occurring within 3 months of hip or knee replacement in patients who received short-duration (7 to 10 days) anticoagulant prophylaxis. Searching MEDLINE, EMBASE and the Cochrane Controlled Trials Register were searched for studies of anticoagulant prophylaxis after hip or knee replacement that were published between

DARE.2002

125. Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty

Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty Nerurkar J, Wade W E, Martin B C Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Two prophylaxis modalities for deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients who had undergone total knee replacement (TKR) were studied. The use of low molecular weight heparin or adjusted-dose warfarin was considered. Type of intervention Primary

NHS Economic Evaluation Database.2002

126. Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial.

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial. 12433510 2002 11 15 2002 11 26 2015 06 16 0140-6736 360 9344 2002 Nov 09 Lancet (London, England) Lancet Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial. 1441-7 Heparins substantially reduce the risk of thromboembolic (...) complications after total hip or knee replacement. However, they can be given only by injection and have several other drawbacks. We did a multicentre, randomised, double-blind study to examine the dose-response relation of subcutaneous melagatran, a direct thrombin inhibitor, followed by oral ximelagatran as thromboprophylaxis after total hip or knee replacement. We aimed to compare the efficacy and safety with that of dalteparin. Of 1900 patients, 1495 were assigned to four dose categories of subcutaneous

Lancet2002

127. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials Eikelboom J W, Quinlan D J, Douketis J D Authors' objectives To assess (...) the efficacy and safety of extended-duration prophylaxis on symptomatic thromboembolic events after total hip or knee replacement. Searching MEDLINE and EMBASE were searched from January 1980 to July 2000 using the following terms: 'thrombosis', 'thromboembolism', 'pulmonary embolism', 'randomised controlled trials', 'controlled clinical trials', 'random', 'placebo', 'hip arthroplasty' and 'knee arthroplasty', in combination with generic and trade terms of individual LMWH preparations. In addition

DARE.2001

128. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement

Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement Bell G K, Goldhaber S Z Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief (...) summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Low molecular weight heparins (LMWHs) were compared with warfarin for prophylaxis following total hip (THR) or total knee (TKR) replacement. Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis. Study population The study population comprised hospital records from patients admitted for THR and TKR

NHS Economic Evaluation Database.2001

129. Autologous blood transfusion in total knee replacement surgery

Autologous blood transfusion in total knee replacement surgery Autologous blood transfusion in total knee replacement surgery Autologous blood transfusion in total knee replacement surgery Thomas D, Wareham K, Cohen D, Hutchings H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Autologous blood transfusion (transfusion using post-operative red cell salvage (PRCS)) was assessed. This involved the use of collected blood which was washed and re-suspended in saline before re-infusion using a centrifugal cell washing machine (Cell Saver 5 Haemonetics). Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population The study population comprised patients undergoing total knee replacement (TKR

NHS Economic Evaluation Database.2001

130. The Oxford unicompartmental knee replacement for osteoarthritis

The Oxford unicompartmental knee replacement for osteoarthritis The Oxford unicompartmental knee replacement for osteoarthritis The Oxford unicompartmental knee replacement for osteoarthritis Brown A Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Brown A. The Oxford unicompartmental knee replacement for osteoarthritis. Ottawa: Canadian (...) Coordinating Office for Health Technology Assessment/Office Canadien de Coordination de l'Evaluation des Technologies de la Sante (CCOHTA) 2001: 4 Authors' objectives To summarise the available evidence on the use of the Oxford unicompartmental knee replacement for osteoarthritis. Authors' conclusions The Oxford unicompartmental knee replacement is a reliable treatment for medial knee compartment osteoarthritis, provided patients with the correct indications are chosen and the appropriate surgical

Health Technology Assessment (HTA) Database.2001

131. Knee replacement : a guide to good practice

Knee replacement : a guide to good practice %PDF-1.3 %bcOS 146 0 obj > endobj xref 146 21 0000000016 00000 n 0000001175 00000 n 0000001343 00000 n 0000001476 00000 n 0000001677 00000 n 0000002229 00000 n 0000002265 00000 n 0000002312 00000 n 0000002359 00000 n 0000002545 00000 n 0000002659 00000 n 0000003037 00000 n 0000003394 00000 n 0000003587 00000 n 0000006254 00000 n 0000040522 00000 n 0000060000 00000 n 0000060853 00000 n 0000068922 00000 n 0000069775 00000 n 0000000716 00000 n trailer

Publication 10832001

132. [Cost-effectiveness analysis of an autotransfusion program in primary knee and hip replacement surgery]

[Cost-effectiveness analysis of an autotransfusion program in primary knee and hip replacement surgery] Analisis de la relacion coste-efectividad de un programa de autotransfusion en cirugia protesica primaria de rodilla y cadera [Cost-effectiveness analysis of an autotransfusion program in primary knee and hip replacement surgery] Analisis de la relacion coste-efectividad de un programa de autotransfusion en cirugia protesica primaria de rodilla y cadera [Cost-effectiveness analysis (...) of an autotransfusion program in primary knee and hip replacement surgery] Diaz-Espallardo C, Moral-Garcia V Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of an autotransfusion programme in patients undergoing primary prosthetic surgery

NHS Economic Evaluation Database.1999

133. Costs and cost-effectiveness in hip and knee replacements: a prospective study

Costs and cost-effectiveness in hip and knee replacements: a prospective study Costs and cost-effectiveness in hip and knee replacements: a prospective study Costs and cost-effectiveness in hip and knee replacements: a prospective study Rissanen P, Aro S, Sintonen H, Asikainen K, Slatis P, Paavolainen P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Total hip (THA) and knee (TKA) replacements in patients with primary arthrosis, primary operation, and total joint replacement. Type of intervention Treatment. Economic study type Cost-utility analysis. Study population Patients with primary arthrosis, primary operation, and total joint replacement. Setting Hospital. The economic study was carried out in Finland. Dates

NHS Economic Evaluation Database.1997

134. Cost effectiveness of revision total knee replacement

Cost effectiveness of revision total knee replacement Cost effectiveness of revision total knee replacement Cost effectiveness of revision total knee replacement Rorabeck C H, Murray P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health (...) technology A revision total knee replacement versus a primary total knee replacement in patients undergoing knee replacement surgery. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Patients undergoing either a revision or a primary total knee replacement. Setting Hospital. The economic study was carried out in Canada. Dates to which data relate The effectiveness and resource use data were collected in 1994. The fiscal year was 1994. Source

NHS Economic Evaluation Database.1997

135. Patient outcomes following tricompartmental total knee replacement: a meta-analysis

Patient outcomes following tricompartmental total knee replacement: a meta-analysis Patient outcomes following tricompartmental total knee replacement: a meta-analysis Patient outcomes following tricompartmental total knee replacement: a meta-analysis Callahan C M, Drake B G, Heck D A, Dittus R S Authors' objectives To provide estimates of patient outcomes following tricompartmental knee replacement, and to examine variation in outcomes due to patient and prosthesis characteristics. Searching (...) interventions included in the review Tricompartmental knee replacement using 37 different prostheses of 4 differing types: posterior cruciate ligament sparing; anterior and posterior cruciate ligament sacrificing without posterior cruciate ligament substitution; anterior and posterior cruciate ligament sacrificing with posterior cruciate ligament substitution; anterior and posterior cruciate ligament sacrificing with posterior cruciate and collateral ligament substitution. Participants included

DARE.1994

136. Cognitive and functional competence after anaesthesia in patients aged over 60: controlled trial of general and regional anaesthesia for elective hip or knee replacement.

Cognitive and functional competence after anaesthesia in patients aged over 60: controlled trial of general and regional anaesthesia for elective hip or knee replacement. 2390547 1990 09 28 1990 09 28 2017 02 19 0959-8138 300 6741 1990 Jun 30 BMJ (Clinical research ed.) BMJ Cognitive and functional competence after anaesthesia in patients aged over 60: controlled trial of general and regional anaesthesia for elective hip or knee replacement. 1683-7 To determine the influence of general (...) or regional anaesthesia on long term mental function in elderly patients. Prospective study of patients randomly allocated to receive general or regional anaesthesia. The patients' homes and a large teaching hospital in Cardiff. 146 Patients aged 60 and over scheduled for elective hip or knee replacement. Scores achieved in tests of cognitive function and functional competence. 72 Patients were allocated to receive general anaesthesia and 74 regional anaesthesia. Anaesthetic technique did not influence

BMJ1990 Full Text: Link to full Text with Trip Pro